1
|
Sampaio TBP, Costa BB, Moreira TA, Cabral LM, Silva LCRP, Mourão PAS, Vilanova E, Cinelli LP. Insights on chemical-biological correlations learned from investigations on the sulfated galactan from the marine alga Bothryocladia occidentalis. Int J Biol Macromol 2020; 158:471-476. [PMID: 32376249 DOI: 10.1016/j.ijbiomac.2020.04.085] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Revised: 04/02/2020] [Accepted: 04/12/2020] [Indexed: 11/25/2022]
Abstract
Marine organisms have been proven to be a valuable source of bioactive compounds. Among them, we highlight the sulfated galactans (SGs) from seaweeds, which besides being massively exploited as industrial thickening and gelling agents (agarans and carrageenans), have also shown promising pharmacological properties. Investigations on the non-agaran/-carrageenan SG from the red algae Bothryocladia occidentalis (SGBo) have demonstrated clear correlations between physical-chemical features and biological activities. SGBo is composed of 2,3-disulfated (~33%) or 2-sulfated (33%) α-D-galactose linked to non- or 2-sulfated β-D-galactose repetitive disaccharide units. The notable serpin-dependent/-independent anticoagulant activity of SGBo (~130 international units [IU]/mg) is higher than those of other SGs containing less 2,3-disulfated α-D-galactose units and their low-molecular-weight derivatives, and thus is directly correlated to its high molecular mass (>200 kDa) and sulfation pattern. Although SGBo has antithrombotic efficacy equivalent to heparin and decreased bleeding potential at low-doses, high-doses substantially increase thrombus formation in animal models. Such an odd dose-dependent dual antithrombotic/prothrombotic activity has been attributed to the ability of SGBo to activate factor XII. In addition to anticoagulant properties, SGBo also exerts antimalarial, antileishmanial and antiophidic activities, and, therefore, has a remarkable potential for the research and development of novel drugs.
Collapse
Affiliation(s)
- Thamiris B P Sampaio
- Laboratório Integrado de Prospecção em Produtos Bioativos, Campus Professor Aloisio Teixeira, Universidade Federal do Rio de Janeiro, Macaé 27930-560, Brazil
| | - Bianca B Costa
- Laboratório Integrado de Prospecção em Produtos Bioativos, Campus Professor Aloisio Teixeira, Universidade Federal do Rio de Janeiro, Macaé 27930-560, Brazil
| | - Thamyris A Moreira
- Laboratório Integrado de Prospecção em Produtos Bioativos, Campus Professor Aloisio Teixeira, Universidade Federal do Rio de Janeiro, Macaé 27930-560, Brazil
| | - Lucio M Cabral
- Laboratório de Tecnologia Industrial Farmacêutica, Departamento de Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-599, Brazil
| | - Luiz C R P Silva
- Laboratório de Tecnologia Industrial Farmacêutica, Departamento de Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-599, Brazil
| | - Paulo A S Mourão
- Laboratório de Tecido Conjuntivo, Instituto de Bioquímica Médica Leopoldo de Meis and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil
| | - Eduardo Vilanova
- Laboratório de Tecido Conjuntivo, Instituto de Bioquímica Médica Leopoldo de Meis and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
| | - Leonardo P Cinelli
- Laboratório Integrado de Prospecção em Produtos Bioativos, Campus Professor Aloisio Teixeira, Universidade Federal do Rio de Janeiro, Macaé 27930-560, Brazil.
| |
Collapse
|
2
|
Gómez-Betancur I, Gogineni V, Salazar-Ospina A, León F. Perspective on the Therapeutics of Anti-Snake Venom. Molecules 2019; 24:E3276. [PMID: 31505752 PMCID: PMC6767026 DOI: 10.3390/molecules24183276] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2019] [Revised: 09/04/2019] [Accepted: 09/06/2019] [Indexed: 01/22/2023] Open
Abstract
Snakebite envenomation is a life-threatening disease that was recently re-included as a neglected tropical disease (NTD), affecting millions of people in tropical and subtropical areas of the world. Improvement in the therapeutic approaches to envenomation is required to palliate the morbidity and mortality effects of this NTD. The specific therapeutic treatment for this NTD uses snake antivenom immunoglobulins. Unfortunately, access to these vital drugs is limited, principally due to their cost. Different ethnic groups in the affected regions have achieved notable success in treatment for centuries using natural sources, especially plants, to mitigate the effects of snake envenomation. The ethnopharmacological approach is essential to identify the potential metabolites or derivatives needed to treat this important NTD. Here, the authors describe specific therapeutic snakebite envenomation treatments and conduct a review on different strategies to identify the potential agents that can mitigate the effects of the venoms. The study also covers an increased number of literature reports on the ability of natural sources, particularly plants, to treat snakebites, along with their mechanisms, drawbacks and future perspectives.
Collapse
Affiliation(s)
- Isabel Gómez-Betancur
- Ophidism-Scorpionism Program, Faculty of Pharmaceutical and Food Sciences, University of Antioquia UdeA, Medellín 1226, Colombia.
| | - Vedanjali Gogineni
- Analytical Department, Cambrex Pharmaceuticals, Charles City, IA 50616, USA.
| | - Andrea Salazar-Ospina
- Research group in Pharmacy Regency Technology, Faculty of Pharmaceutical and Food Sciences University of Antioquia UdeA, Medellín 1226, Colombia.
| | - Francisco León
- College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
| |
Collapse
|
3
|
de Jesus Raposo MF, de Morais AMB, de Morais RMSC. Marine polysaccharides from algae with potential biomedical applications. Mar Drugs 2015; 13:2967-3028. [PMID: 25988519 PMCID: PMC4446615 DOI: 10.3390/md13052967] [Citation(s) in RCA: 322] [Impact Index Per Article: 35.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Revised: 04/26/2015] [Accepted: 05/04/2015] [Indexed: 02/06/2023] Open
Abstract
There is a current tendency towards bioactive natural products with applications in various industries, such as pharmaceutical, biomedical, cosmetics and food. This has put some emphasis in research on marine organisms, including macroalgae and microalgae, among others. Polysaccharides with marine origin constitute one type of these biochemical compounds that have already proved to have several important properties, such as anticoagulant and/or antithrombotic, immunomodulatory ability, antitumor and cancer preventive, antilipidaemic and hypoglycaemic, antibiotics and anti-inflammatory and antioxidant, making them promising bioactive products and biomaterials with a wide range of applications. Their properties are mainly due to their structure and physicochemical characteristics, which depend on the organism they are produced by. In the biomedical field, the polysaccharides from algae can be used in controlled drug delivery, wound management, and regenerative medicine. This review will focus on the biomedical applications of marine polysaccharides from algae.
Collapse
Affiliation(s)
- Maria Filomena de Jesus Raposo
- CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Rua Arquiteto Lobão Vital, Apartado 2511, 4202-401 Porto, Portugal.
| | - Alcina Maria Bernardo de Morais
- CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Rua Arquiteto Lobão Vital, Apartado 2511, 4202-401 Porto, Portugal.
| | - Rui Manuel Santos Costa de Morais
- CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Rua Arquiteto Lobão Vital, Apartado 2511, 4202-401 Porto, Portugal.
| |
Collapse
|
4
|
Pires CL, Rodrigues SD, Bristot D, Hessel Gaeta H, de Oliveira Toyama D, Ronald Lobo Farias W, Hikari Toyama M. Sulfated polysaccharide extracted of the green algae Caulerpa racemosa increase the enzymatic activity and paw edema induced by sPLA2 from Crotalus durissus terrificus venom. REVISTA BRASILEIRA DE FARMACOGNOSIA 2013. [DOI: 10.1590/s0102-695x2013005000050] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
5
|
Jiao G, Yu G, Zhang J, Ewart HS. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar Drugs 2011; 9:196-223. [PMID: 21566795 PMCID: PMC3093253 DOI: 10.3390/md9020196] [Citation(s) in RCA: 560] [Impact Index Per Article: 43.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2010] [Revised: 01/15/2011] [Accepted: 01/26/2011] [Indexed: 12/01/2022] Open
Abstract
Sulfated polysaccharides and their lower molecular weight oligosaccharide derivatives from marine macroalgae have been shown to possess a variety of biological activities. The present paper will review the recent progress in research on the structural chemistry and the bioactivities of these marine algal biomaterials. In particular, it will provide an update on the structural chemistry of the major sulfated polysaccharides synthesized by seaweeds including the galactans (e.g., agarans and carrageenans), ulvans, and fucans. It will then review the recent findings on the anticoagulant/antithrombotic, antiviral, immuno-inflammatory, antilipidemic and antioxidant activities of sulfated polysaccharides and their potential for therapeutic application.
Collapse
Affiliation(s)
- Guangling Jiao
- National Research Council Canada, Institute for Marine Biosciences, Halifax, NS, B3H 3Z1, Canada;
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, China
| | - Guangli Yu
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, China
| | - Junzeng Zhang
- National Research Council Canada, Institute for Nutrisciences and Health, Charlottetown, PEI, C1A 4P3, Canada;
| | - H. Stephen Ewart
- National Research Council Canada, Institute for Marine Biosciences, Halifax, NS, B3H 3Z1, Canada;
| |
Collapse
|